MIR4787

Across TCGA pan-cancer cohorts, MIR4787 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR4787’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR4787 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR4787 is over-expressed in tumor, although a few such as STAD and ESCA show the opposite, repressed pattern.

STAD and ESCA are the cancer types where MIR4787 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4787 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	−0.988	.002	4	view →
ESCA	All	All	−0.758	.035	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MIR4787–STAD

Open the STAD breakdown →